Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of GS-5745 (andecaliximab) in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GS-5745

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED